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Abstract
Background: Leber hereditary optic neuropathy (LHON, MIM 535000) is one of the most common mitochondrial genetic
disorders caused by three primary mtDNA mutations (m.3460G.A, m.11778G.A and m. 14484T.C). The clinical expression
of LHON is affected by many additional factors, e.g. mtDNA background, nuclear genes, and environmental factors. Hitherto,
there is no comprehensive study of Chinese LHON patients with m.14484T.C.
Methodology/Principal Findings: In this study, we analyzed the mtDNA sequence variations and haplogroup distribution
pattern of the largest number of Chinese LHON patients with m.14484T.C to date. We first determined the complete
mtDNA sequences in eleven LHON probands with m.14484T.C, to discern the potentially pathogenic mutations that co-
segregate with m.14484T.C. We then dissected the matrilineal structure of 52 patients with m.14484T.C (including 14
from unrelated families and 38 sporadic cases) and compared it with the reported Han Chinese from general populations.
Complete mtDNA sequencing showed that the eleven matrilines belonged to nine haplogroups including Y2, C4a, M8a,
M10a1a, G1a1, G2a1, G2b2, D5a2a1, and D5c. We did not identify putatively pathogenic mutation that was co-segregated
with m.14484T.C in these lineages based on the evolutionary analysis. Compared with the reported Han Chinese from
general populations, the LHON patients with m.14484T.C had significantly higher frequency of haplogroups C, G, M10, and
Y, but a lower frequency of haplogroup F. Intriguingly, we also observed a lower prevalence of F lineages in LHON subjects
with m.11778G.A in our previous study, suggesting that this haplogroup may enact similar role during the onset of LHON
in the presence of m.14484T.C or m.11778G.A.
Conclusions/Significance: Our current study provided a comprehensive profile regarding the mtDNA variation and
background of Chinese patients with LHON and m.14484T.C. Matrilineal background might affect the expression of LHON
in Chinese patients with m.14484T.C.
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Introduction
Leber hereditaryoptic neuropathy(LHON, MIM 535000)is one
of the most common mitochondrial genetic disorders caused by
mtDNA point mutation [1] and causes visual loss in young adults.
The clinical diagnosis of LHON is mainly based on ophthalmologic
features and molecular genetic testing for three primary mutations
(m.3460G.A in the MT-ND1 gene, m.11778G.A in the MT-ND4
gene, and m.14484T.Cin the MT-ND6gene) [1–6]. Over 95%of
LHON patients carries one of the three primary mutations [2], but
not all individuals will develop typical symptom of LHON (viz.
incomplete penetrance), which suggests that some additional
factors, e.g. other mtDNA mutations, mtDNA background, nuclear
genes, and environmental factors, may be involved in the
phenotypic expression, severity, and recovery of this disorder
[1,2,7–10]. Indeed, the three primary mutations are prerequisites
for LHON, and many other rare LHON mutations are dis-
covered continuously (c.f. http://www.mitomap.org/MITOMAP/
MutationsLHON). For instance, mutation m.3635G.A was
reported in several LHON families without the three primary
mutations and appeared to be one of LHON primary mutations in
Chinese families [11–13]. Mutations m.3736G.A (p.V144I) and
m.10680G.A (p.A71T) were also among the list of pathogenic
mutations for Chinese patients with LHON or suspected LHON
[14].
Among these factors that affect the clinical expression of
LHON, mtDNA background/haplogroup, which was formed
during the migration of the ancestor of modern human across
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[9,15]. Those early reports for secondary mutations for LHON in
patients from Europe or of European origin, e.g. m.4216T.C,
m.13708G.A, and m.15257G.A [16–18] were actually hap-
logroup-specific variants for haplogroup J2. Because of the
continent-specific distribution of mtDNA haplogroups, there is a
remarkable difference of the haplogroups that had an influence on
the expression of LHON between the Western European patients
and East Asian patients. Haplogroups J1, J2, and K increased the
risk of blindness in LHON patients with m.14484T.C,
m.11778G.A, and m.3640G.A, respectively, whereas hap-
logroup H had a protective role in LHON patients with
m.11778G.A in European LHON families [9]. By analyzing
the LHON penetrance pattern in Chinese families with
m.11778G.A, we recently found that haplogroup M7b192
significantly increased the risk of visual failure and M8a had a
protective effect [15]. Experimental data on LHON hybrid cell
models harboring the three primary LHON mutations showed
that specific mtDNA haplogroup modulated OXPHOS assembly
kinetics [19] or increased the sensitivity to environmental toxicity
[20]. These results further supported the notion that mtDNA
haplogroups played an important role in the onset of LHON.
We identified 537 Chinese LHON patients with one of the
three primary mutations (m.3460G.A, m.11778G.A, or m.
14484T.C) during our recent campaign for comprehensive
mutation screening for this disease in a large cohort of patients
(N=1,626) with clinical feature of LHON or suspected with
LHON [15,21]. Among these LHON patients confirmed by
genetic diagnosis, we identified 52 families/singleton cases
harbored mutation m.14484T.C. In this study, we presented
our analyses for mtDNA sequence variation and haplogroup
classification of these mtDNAs with m.14484T.C. We first
selected eleven LHON probands and determined the complete
mtDNA sequences, to discern potential secondary mtDNA
mutation(s) or co-segregation of pathogenic mutation(s) in these
cases. We then dissected the matrilineal genetic structure of all
LHON patients with m.14484T.C and compared to that of the
general Han Chinese. The direct comparison of each haplogroup
in LHON patients and general Han Chinese showed that there
was a strikingly lower prevalence of haplogroup F in the case
group.
Materials and Methods
Ethics statement
Written informed consents conforming to the tenets of the
Declaration of Helsinki were obtained from each participant prior
to the study. The institutional review boards of the Zhongshan
Ophthalmic Center and the Kunming Institute of Zoology
approved this study.
Patients
Fifty-two patients with LHON and m.14484T.C were
collected from different provinces in China, which were identified
from 537 patients who were genetically diagnosed as LHON
according to the presence of one of the three LHON primary
mutations. The presence of mutation m.14484T.C in these
patients was confirmed at the Kunming Institute of Zoology and at
the Zhongshan Opthalmic Center, independently, by using the
allele-specific PCR, SSCP (single strand conformation polymor-
phism), and/or sequencing [22,23]. Among them, 14 probands
were from pedigrees with a family history of LHON and 38 cases
were sporadic. Note that we defined the proband from a family
with only one patient (according to the accessible pedigree
information) or with unclear family history as sporadic. This
definition for sporadic case also includes the family with several
asymptomatic carriers of m.14484T.C but with only one affected
member (viz. the proband).
mtDNA sequencing
Genomic DNA was extracted from peripheral blood by the
standard phenol-chloroform method. The noncoding control-
region sequences were analyzed in 52 patients as described in our
previous study [15,24]. Coding-region mutation motifs (e.g.
m.5178C.A [MT-ND2: p.L237M; MIM 516001] for haplogroup
D, recognized by -5176 AluI) were screened to further solidify the
haplogroup status for some mtDNAs. The entire mtDNA
sequences of eleven probands were amplified by four overlapping
primers according to our previous study [25]. PCR products were
purified on spin columns (Tiangen Biotech Co., Beijing, China)
and directly sequenced by using the reported inner primers
[25,26] and BigDye Terminator v3.1 Cycle Sequencing Kit
(Applied Biosystems, CA, USA) on a 3730 DNA sequencer
(Applied Biosystems).
Data analysis
We evaluated the penetrance rate of LHON in the pedigrees
based on our previous criterion [14]. Namely, we excluded the
following family members from the analysis: (a) the first
generation, (b) spouses of the matrilineal members, and (c)
children of the male member in each family. Sequence variations
in each proband mtDNA sequence were scored relative to the
revised Cambridge Reference Sequence (rCRS) [27]. We followed
the recently updated version of East Asian mtDNA tree [28] and
the PhyloTree.org database (http://www.phylotree.org) [mtDNA
tree Build 10; 10 Aug 2009] to classify each sample [29]. Potential
sequence abnormalities that were identified by using the
phylogenetic approach [30,31], as performed manually and/or
automatically by the MitoTool (http://www.mitotool.org; this
software was designed by ourselves), were rechecked for the
original sequencing electropherograms or resequencing. We
defined the uniqueness of mtDNA variant(s) in certain matriline
by an exhaustive database search following the available guidelines
[32]. A schematic tree was reconstructed to show the relationship
among these mtDNAs. Evolutionary conservation analysis for
certain mtDNA variant was performed using the same approach
as described in our previous study [15,25]. Statistical analysis was
performed using the SPSS statistical package (version 11.5), and
statistical significance was established at P,0.05.
Results
Prevalence and heteroplasmy of m.14484T.C in Chinese
patients with LHON
Among 537 Chinese patients with LHON and one of the three
primary LHON mutations, 52 subjects were confirmed to harbor
m.14484T.C. The prevalence of m.14484T.C in all 537
LHON patients (9.7%, 52/537) was much lower than that of
European patients, in which 20.8% (33/159) of LHON patients
were caused by this mutation [9]. Note that the presence of
m.14484T.C in the general Han Chinese populations was very
rare and we detected no individual carrying m.14484T.Ci n
1571 subjects (0/1571) in our recent study to screen the three
LHON primary mutations in the general Chinese population [22].
Among all Chinese LHON patients with m.14484T.C, 14
probands (14/52, 26.9%) were self-reported to have a family
history of the disease and 38 cases were sporadic according to our
definition for sporadic case (cf. Materials and Methods section).
mtDNA Variation in LHON
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information for three families (Le405, Le559, and Le691) because
of loss of follow-up message: we failed to get in touch with them
according to the home address in their previous medical record.
We then restricted our analysis to the remaining 11 families to
estimate the affected male-to-female ratio (Fig. 1). Apparently, the
affected male-to-female ratio in these families with m.14484T.C
(5.2:1, [31/6]) was substantially higher than those of families with
m.11778G.A (2.38:1, [436/183]) and m.3460G.A (4:1, [8/2])
[15,21]. The penetrance of LHON in these 11 families varied
differently, despite a fact that some pedigrees were rather small
and this would lead to a biased estimation for the penetrance rate
(Fig. 1). The overall penetrance of LHON in Chinese families with
m.14484T.C (31.9% [37/116]) was within the range that was
observed for Chinese families with m.3460G.A (25.6% [10/39])
[21] and m.11778G.A (33.3% [619/1859]) [15]. There were
only 3 cases (Le1, Le405, and Le567) with a heteroplasmic status
of m.14484T.C in all 52 probands. The frequency of the
heteroplasmy of m.14484T.C in Chinese LHON patients (5.8%,
[3/52]) was lower than that of European patients (36.4%, [8/22])
[33]. Again, this value should be treated with caution, as we did
not screen the heteroplasmy of m.14484T.C in all normal
members from these families.
Absence of co-segregation of pathogenic mutations with
m.14484T.C in Chinese families with LHON
Previous studies have shown that there were potentially
pathogenic variants co-segregated with the primary LHON
mutation and enhanced the clinical expression of LHON [34,35].
To investigate whether there are such variants in Chinese LHON
families, we analyzed the complete mtDNA genomes of eleven
LHON probands harboring m.14484T.C and with a family
history (including one sporadic case Le1123). Probands Le182 and
Le868 were not analyzed for complete mtDNA sequences, because
we used up the limited genomic DNA extracted from dried blood
spots on filter paper during the initial primary mutation screening
and mtDNA control region sequencing. As shown in Fig. 2, these
probands belonged to nine distinct mtDNA haplogroups including
Y2, C4a, M8a, M10a1a, G1a1, G2a1, G2b2, D5a2a1, and D5c.
There were only eight non-synonymous variants, four mt-tRNA
variants, and one 16S rRNA variant in families Le708 (m.644A.G
[MT-TF]; m.4944A.G [MT-ND2: p.I159V]), Le1187
(m.5846C.T[ MT-TY]; m.9137T.C [MT-ATP6: p.I204T]),
Le1304 (m.3397A.G [MT-ND1: p.M31V]), Le1322
(m.4388A.G[ MT-TQ]; m.13708G.A [MT-ND5: p.A458T];
m.15930G.A[ MT-TT]), Le671 (m.7129A.G [MT-CO1:
p.Y409C]; m.15737G.A [MT-CYB: p.D331N]), Le691
(m.2581A.G[ MT-RNR2]; m.4491G.A [MT-ND2: p.V8A])
and Le616 (m.14071A.G [MT-ND5: p.T579A]) at the twig level
of the tree. These thirteen variants had been previously reported in
the general populations (Table 1). Therefore, these private variants
should be best categorized as polymorphisms. Family Le700 had a
high penetrance of LHON (note that this pedigree was rather small
and this would lead to a biased estimation for penetrance), but we
failed to find any potentially pathogenic mutations that had a
synergistic effect with m.14484T.C. This was quite different from
the family that was described by Yang et al. [34], in which mutation
m.10680G.A enhanced the expression of m.14484T.C.
mtDNA haplogroup distribution in Chinese LHON
patients with m.14484T.C
In order to address a possibility whether there is certain mtDNA
haplogroup contributing to the clinical expression of LHON in
Chinese patients with m.14484T.C, we analyzed the mtDNA
control-region sequences of the 52 probands with m.14484T.C
and classified each mtDNA into respective haplogroup (Table S1).
All the subjects could be classified into 17 haplogroups based on
the control-region sequence motif recognition and matching or
near-matching with the published mtDNAs [36] (Table 2).
Compared with the pooled Han Chinese population from
published sources ([36,37] and references therein), we found that
haplogroups C (P=0.002, OR=5.614, 95% CI=2.072–15.208),
G( P=0.017, OR=3.671, 95% CI=1.345–10.018), M10
(P=0.036, OR=4.167, 95% CI=1.209–14.356), and Y
(P=0.018, OR=5.583, 95% CI=1.521–20.489) had significantly
higher frequencies in the LHON subjects. Only one out of the 52
probands with m.14484T.C belonged to haplogroup F. The
frequency of haplogroup F (1.9%, 1/52) was significantly lower
than that of the Han Chinese from general populations (16.67%,
68/408) (P=0.003, OR=0.098, 95% CI=0.013–0.722), which
suggested a possibly protective effect of this matrilineal back-
ground on LHON (Table 2).
The complete mtDNA and control-region sequences generated
in this study have been deposited in GenBank under accession
numbers HM460791-HM460842 and HQ260970-HQ260973.
Discussion
LHON patients with mutation m.14484T.C exhibited some
unique characteristics compared with LHON patients caused by
the other primary mutations, such as better visual recovery,
obvious gender bias, and higher occurrence in haplogroup J1 in
European populations [1]. In this study, we presented an analysis
of the largest number of Chinese patients with LHON and
m.14484T.C, with an intention to discern potentially pathogenic
mutations that were co-segregated with m.14484T.C and to
dissect the matrilineal genetic structure of Chinese LHON patients
with this mutation. The frequency of mutation m.14484T.C
(9.7%) was significantly lower in Chinese LHON patients than
that of European patients (20.8%) [9,15,23], suggesting racial
difference.
Among the eleven probands that were sequenced the entire
mtDNA genome, we identified eight private non-synonymous
variants, four mt-tRNA variants, and one 16S rRNA variant in the
terminal branches of the classification tree (Fig. 2). A web-based
search [32] and evolutionary analysis for these private variants
showed that none of these variants would enact a synergistic effect
with m.14484T.C. It thus seemed that the variable level of
penetrance of LHON in these families was modulated by a
complex involvement of the effect of primary mutation
m.14484T.C, mtDNA background, nuclear genetic background,
as well as environmental factor. Although we did not determine
the entire mtDNA sequences for all the remaining 41 subjects with
m.14484T.C, we would expect that there was no co-segregation
of pathogenic mutations with m.14484T.C on the basis of the
pattern observed in the 11 families.
The dissection of the matrilineal genetic structure of Chinese
LHON subjects with m.14484T.C yielded several interesting
findings. First, haplogroup F had a high incidence in South China
and the overall frequency of this haplogroup ranged 6%–25.9%
across China [36]. In the pooled Han Chinese from general
populations, this haplogroup had a frequency of 16.7% (68/408),
much higher than what we observed for the LHON subjects with
m.14484T.C (1.9%; 1/52). This result was unexpected, but a
extremely low occurrence of haplogroup F had been observed in
Chinese LHON patients with m.11778G.A (2.2%; 4/182) [15]
and in 40 LHON patients harboring m.11778G.A from Thai-
mtDNA Variation in LHON
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haplogroup F in Chinese LHON families with m.14484T.C and
m.11778G.A remains unclear. An audit for the haplogroup-
specific variants for haplogroup F revealed no seemingly useful
information for us to deduct the putative role of this genetic
background, as the three haplogroup-characteristic polymor-
phisms (m.249delA in the mtDNA control-region, m.6392T.C
in the MT-CO1 gene, and m.10310G.A in the MT-ND3 gene)
Figure 1. Pedigree information for Chinese LHON families with m.14484T.C. Affected individuals are marked by filled symbols. Arrows
indicate the probands that were analyzed for mtDNA sequence variations in this study. Three families with a disease history but lacked of follow-up
message (Le405, Le559 and Le691) were not included here for analysis. Probands Le865 and Le1123 were considered as sporadic cases according to
our definition for being sporadic.
doi:10.1371/journal.pone.0013426.g001
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acid change. Whether there are some interactions between
haplogroup F and nuclear genes or environmental factors in these
LHON families is an intriguing yet pending puzzle.
Second, haplogroups C, G, Y, and M10 seemed to be more
common in Chinese LHON subjects with m.14484T.Ct h a n
those of Han Chinese from general populations. However, any
claim for potential association between these four haplogroups
and the risk of LHON should be received with caution and
verified by a large sample size. Haplogroup G was found to be
possibly associated with the clinical expression of LHON in
Chinese families with m.11778G.A in our previous study [15].
However, the penetrance of LHON in the three families with
m.14484T.C (,Le616, Le700, and Le1322) belonging to
haplogroup G varied substantially (Fig. 1). The putative effect
of haplogroup G-specific variant m.4833A.G (p.T122A) on the
risk of LHON [15] in these LHON families needs further study.
The higher prevalence of haplogroup Y in LHON patients with
m.14484T.C was puzzling, as this haplogroup was generally
infrequent in East Asian [36]. Among the list of haplgroup
Y specific polymorphisms, two non-synonymous variants,
m.10398A.G (p.T114A) and m.14178T.C (p.I166V), and
one tRNA-Glu variants (m.14693A.G) might deserve some
attention. Variant m.10398A.G was reported to be associated
Figure 2. Classification tree of the entire mtDNA sequences of eleven matrilines with m.14484T.C, plus the revised Cambridge
reference sequence (rCRS). The order of mutations/variants on each uninterrupted branch section is arbitrary. Back variants are highlighted by the
prefix ‘‘@’’, and recurrent variants are underlined. Suffix ‘+C’ indicates an insertion of cytosine. The primary mutation m.14484T.Ci si nbold. The
heteroplasmic status was marked by ‘‘(h)’’. The synonymous and non-synonymous coding-region variants in the eleven mtDNAs are denoted by ‘‘/s’’
and ‘‘/ns’’, respectively. Variations in the transfer RNA and the ribosomal RNA genes are denoted by ‘‘/t’’ and ‘‘/r’’, respectively.
doi:10.1371/journal.pone.0013426.g002
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Family/
subject
a Haplogroup
Nucleotide variant
(amino acid change) Gene
Reported
(population
context)
b
Reported
(disease
context)
b Conservation
c
Haplogroup-specific
variant
d
Le708 Y2 m.644A.G MT-TF Yes Yes No Yes (M38b)
m.4944A.G (p.I159V) MT-ND2 Yes Yes No No
Le1187 C4a m.5846C.T MT-TY Yes No No No
m.9137T.C (p.I204T) MT-ATP6 Yes Yes No No
Le1304 M10a1a m.3397A.G (p.M31V) MT-ND1 Yes Yes No Yes (C5d1a, M27c, R0a2j)
Le616 G2a1 m.14071A.G (p.T579A) MT-ND5 No Yes No No
Le1322 G2b2 m.4388A.G MT-TQ Yes Yes Yes Yes (L3h1)
m.13708G.A (p.A458T) MT-ND5 Yes Yes No Yes (M5c1, C7a1a2, M12b, etc)
m.15930G.A MT-TT Yes Yes No Yes (L0d)
Le691 D5a2 m.2581A.G MT-RNR2 Yes Yes No Yes (H3b)
m.4491G.A (p.V8A) MT-ND2 Yes Yes No Yes (L1c1a1a2, L3c, M9)
Le671 D5c m.7129A.G (p.Y409C) MT-CO1 Yes Yes No Yes (L3x2a1)
m.15737G.A (p.D331N) MT-CYB Yes Yes No No
aThecompletemtDNAgenomesofLe789,Le1123, Le700andLe338contained no privatenon-synonymous,mt-rRNA,andmt-tRNAvariants, andwerenot included in the table.
bThesearch was performed onSeptember13, 2010following thesamestrategy described in Bandelt etal.[32], e.g.,both ‘A644GmtDNA’ and ‘644A.Gm t D N A ’w e r eq u e r i e d .
cThe conservation analysis was performed by comparing Homo sapiens mtDNA (GenBank accession no. J01415) to nine different vertebrate species, Gorilla gorilla
(NC_001645), Mus musculus (AY466499), Bos taurus (AY526085), Equus caballus (EF597513), Canis lupus chanco (EU442884), Canis familiaris (DQ480502), Balaenoptera
musculus (NC_001601), Rana nigromaculata (AB043889), and Danio rerio (NC_002333).
dThe column ‘‘Haplogroup-specific variant’’ refers to the presence or absence of the corresponding variants in the world mtDNA phylogeny displayed at http://www.
phylotree.org/tree/main.htm (mtDNA tree Build 10; 10 Aug 2009) [29]. In round brackets we indicated the haplogroup status as it defined in that tree.
doi:10.1371/journal.pone.0013426.t001
Table 2. Haplogroup distribution of 52 Chinese LHON subjects with m.14484T.C.
Haplogroup
No. of subjects with
m.14484T.C (%)
No. of Han Chinese from
general populations (%)
a p value
b Odds Ratio 95% CI
B4 3 (5.77) 55 (13.48) 0.180 0.393 0.118–1.304
B5 5 (9.62) 17 (4.17) 0.090 2.447 0.863–6.937
C 7 (13.46) 11 (2.70) 0.002 5.614 2.073–15.208
D4 6 (11.54) 56 (13.73) 0.830 0.820 0.335–2.009
D5 4 (7.69) 27 (6.62) 0.768 1.176 0.395–3.505
F 1 (1.92) 68 (16.67) 0.003 0.098 0.013–0.722
G 6 (11.54) 14 (3.43) 0.017 3.671 1.345–10.018
M10 4 (7.69) 8 (1.96) 0.036 4.167 1.209–14.355
M12 1 (1.92) 2 (0.49) 0.303 3.980 0.355–44.676
M7b 5 (9.62) 24 (5.88) 0.356 1.702 0.620–4.673
M8a 1 (1.92) 18 (4.41) 0.710 0.425 0.056–3.250
M9a 1 (1.92) 10 (2.45) 1.000 0.780 0.098–6.223
N9a 1 (1.92) 15 (3.68) 1.000 0.514 0.066–3.971
Y 4 (7.69) 6 (1.47) 0.018 5.583 1.522–20.488
Z 1 (1.92) 8 (1.96) 1.000 0.980 0.120–8.000
U 1 (1.92) 3 (0.74) 0.382 2.647 0.270–25.927
R9 excluding F
c 1 (1.92) 6 (1.47) 0.571 1.314 0.155-11.132
Other
d 0 (0) 60 (14.71) 0.001 - -
aThe Han Chinese from general populations were taken from published sources ([36,37] and references therein).
bThe Fisher exact test (two-tailed) was performed to discern the frequency difference of certain haplogroup between the LHON subjects (N=52) and Han Chinese from
the general populations (N=408).
cOnly mtDNAs belonging to R9b and R9c were considered here, mtDNAs belonging to haplogroup F were not included.
dThose haplogroups that were not observed in the LHON patients but in reported Han Chinese were grouped together.
doi:10.1371/journal.pone.0013426.t002
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said to play a role in mitochondrial matrix pH and intracellular
calcium dynamics [41]. However, any speculation for a putative
role of this variant or haplogroup Y in Chinese LHON subjects
with m.14484T.C should be further tested with more samples
and functional assay. In Han Chinese, besides these mtDNAs
belonging to haplogroup Y, all mtDNAs belonging to (1) macro-
haplogroup M and its subhaplogroups and (2) haplogroups R11,
B4c1c, B5 contain m.10398A.G. Therefore, in our LHON
patients, the frequency of m.10398A.G could be calculated by
adding up the number of lineages belonging to the above
haplogroups, then divided by the total number of samples (45/
52=86.54%). The frequency of m.10398A.G in Han Chinese
from general populations could be estimated as 223/
408=54.66%. The frequency difference of m.10398A.G
between the case group and the control group was statistically
significant (P=0.000005, Fisher’s exact test, two-tailed), suggest-
ing that m.10398A.G might act as a potentially confounding
factor for m.14484T.C. Again, this result should be treated with
caution because of the small sample size of the patients under
study.
The higher frequency of haplogroups C and M10 in LHON
patients with m.14484T.C was also interesting, as population
substructure might not well explain this pattern; but again this
observation might be affected by the small sample size of the case
group. Note that the four LHON subjects belonging to M10 could
be further classified into haplogroup M10a1, which is character-
ized by one non-synonymous variant m.13135G.A (p.A267T) in
the MT-ND5 gene. A previous study reported that m.13135G.A
was associated with familial hypertrophic cardiomyopathy in
Chinese [42].
In summary, we presented here the genetic analysis of the
largest number of Chinese LHON patients with m.14484T.Ct o
date. We found no pathogenic mutation that was co-segregated
with m.14484T.C in all eleven LHON probands that were
analyzed for complete mtDNA genome sequences. Noteworthily,
the matrilineal genetic structure of the LHON subjects differed
from that of Han Chinese from the general populations
substantially, with fewer lineages belonging to haplogroup F and
higher number of lineages to haplogroups G, C, Y, and M10 in the
LHON subjects with m.14484T.C. How and why these mtDNA
haplogroups presented such a unique pattern need further study
with more samples. Our current study provided an overall
matrilineal genetic profile for Chinese LHON patients with
m.14484T.C and might be useful for genetic counseling.
Extensive analysis of more families would help to further define
the risk factors in Chinese patients with m.14484T.C.
Supporting Information
Table S1 mtDNA sequence variation and haplogroup classifi-
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